Mesenchymal Stem Cells Mediated Drug Delivery in Tumor-Targeted Therapy

Mesenchymal Stem Cells (MSCs) possess unique properties that make them potential carriers for cancer therapy. MSCs have been documented to have low immunogenicity, positive safety in clini-cal trials, and the ability to selectively perform homing to inflammation and tumor sites. This review aims to introduce tumor tropism mechanism and effects of MSCs on tumor cells, and give an overview of MSCs in delivering gene therapeutic agents, oncolytic viruses and chemotherapeutics, as well as the application of MSCs-derived exosomes in tumor-targeted therapy.

Automated summary

MSCs, with low immunogenicity and the ability to selectively target inflammation and tumor sites, have shown positive safety and potential for cancer therapy. They can deliver gene therapeutic agents, oncolytic viruses, and chemotherapeutics, with promising applications in tumor-targeted therapy.